Methods and compositions for producing clonal, non-reduced, non-recombined gametes

Patent metadata

Field	Value
Publication number	US-12133495-B2
Application number	US-201716085838-A
Country	US
Kind code	B2
Filing date	Mar 17, 2017
Priority date	Mar 18, 2016
Publication date	Nov 5, 2024
Grant date	Nov 5, 2024

Abstract

Methods and compositions useful for avoiding plant meiosis and clonal reproduction through seed are provided herein. The present disclosure provides polynucleotides and related polypeptides of Spo11, Rec8, OSD1-1A, and OSD1-3A and methods and compositions for suppressing their expression level or activity.

First claim

What is claimed is:

1. A maize plant that produces clonal, non-reduced, non-recombined gametes, wherein the maize plant comprises:
a) eliminated Spo11 activity of an endogenous Spo11 polynucleotide or polypeptide, wherein the Spo11 polynucleotide is selected from the group consisting of:
i. a polynucleotide that encodes the polypeptide of SEQ ID NO:16;
ii. a polynucleotide comprising the sequence set forth in SEQ ID NO:13, and
iii. a polynucleotide having at least 95% sequence identity to SEQ ID NO: 13, wherein the Spo11 polypeptide is selected from the group consisting of:
i. a polypeptide that is encoded by a nucleic acid molecule comprising a nucleotide sequence that is at least 95% identical to SEQ ID NO: 13, wherein the Spo11 activity of the endogenous Spo11 polynucleotide or polypeptide is eliminated by introducing a nucleotide modification into the Spo11 polynucleotide sequence or nucleic acid molecule in part a) to knock-out the endogenous Spo11 polynucleotide;

b) eliminated Rec8 activity of an endogenous Rec8 polynucleotide or polypeptide, wherein Rec8 polynucleotide is selected from the group consisting of:
i. a polynucleotide comprising the sequence set forth in SEQ ID NO:9; and
ii. a polynucleotide having at least 95% sequence identity to SEQ ID NO: 9; wherein the Rec8 polypeptide is selected from the group consisting of:
i. a polypeptide that is encoded by a nucleic acid molecule comprising a nucleotide sequence that is at least 95% identical to SEQ ID NO:9, wherein the Rec8 activity of the endogenous Rec8 polynucleotide or polypeptide is eliminated by introducting a nucleotide modification into REC8 Polyculeotide sequence or nucleic acid molecule in part b) to knock-out the endogenour Rec8 polynucleotide;

c) eliminated OSD1-1A activity of an endogenous OSD1-1A poluynucleotide or polypeptide, wherein OSD1-1A polynuycleotide is selected from the group consisting of:
i. a polynucleotide that encodes the polypeptide of SEQ ID NO:4;
ii. a polynucleotide comprising the sequence set forth in SEQ ID NO:1; and
iii. a polynucleotide having at least 95% sequence identitiy of SEQ ID NO:1; wherein the OSD1-1A polypeptide is selected form the group consisting of:
i. a polypeptide that is encoded by a nucleic acid molecule comprising a nucleotide sequence that is at least 95% identical to SEQ ID NO:1,

wherein the OSD1-1A activity of the endogenous OSD1-1A polynucleotide or polypeptide is eliminated by introducing a nucleotide modification into the OSD1-1A polynucleotide sequence or nucleic acid molecule in part c) to knock-out the endogenous OSD1-1A polynucleotide;

and
d) eliminated OSD1-3A activity of an endogenous OSD1-3A polynucleotide or polypeptide, wherein OSD1-3A polynucleotide is selected from the group consisting of:
i. a polynucleotide that encodes the polypeptide of SEQ ID NO:8;
ii. a polynucleotide comprising the sequence set forth in SEQ ID NO:5; and
iii. a polynucleotide having at least 95% sequence identity to SEQ ID NO:5; wherein the OSD1-3A polypeptide is selected form the group consisting of:
i. a polypeptide that is encoded by a nucleic acid molecule comprising a nucleotide sequence that is at least 95% identical to SEQ ID NO: 5,

wherein the OSD1-3A activity of the endogenous OSD1-3A polynucleotide or polypeptide is eliminated by introducing a nucleotide modification into the OSD1-3A polynucleotide sequence of nucleic acid molecule in part d) to knock-out the endogenous OSD1-3A polynucleotide.

2. The maize plant of claim 1 , wherein the maize plant is a hybrid.

3. The maize plant of claim 1 , wherein the maize plant is a female parent.

4. The maize plant of claim 1 , wherein the introduced nucleotide modification is a deletion, addition, or substitution of one or more nucleotides.

5. The maize plant of claim 1 , wherein the introduced amino acid modification is a deletion, addition, or substitution of one or more amino acids.

6. The maize plant of claim 1 , wherein said the nucleotide modification is introduced by a nuclease selected from the group consisting of: a TALEN, a meganuclease, a zinc finger nuclease, and a CRISPR-associated nuclease.

7. The maize plant of claim 6 , wherein the nucleotide modification is introduced by a Cas9 endonuclease guided by at least one guide RNA.

8. A method for obtaining a maize plant producing clonal, non-reduced, non-recombined gametes, the method comprising:
a) eliminating in the maize plant the Spo11 activity of an endogenous Spo11 polynucleotide or polypeptide, wherein the Spo11 polynucleotide is selected from the group consisting of:
i. a polynucleotide that encodes the polypeptide of SEQ ID NO:16;
ii. a polynucleotide comprising the sequence set forth in SEQ ID NO:13; and
iii. a polynucleotide having at least 95% sequence identity to SEQ ID NO: 13;

wherein the Spo11 polypeptide is selected from the group consisting of:
i. a polypeptide that is encoded by a nucleic acid molecule comprising a nucleotide sequence that is at least 95% identical to SEQ ID NO:13;

b) eliminating in the maize plant the Rec8 activity of an endogenous Rec8 polynucleotide or polypeptide, wherein Rec8 polynucleotide is selected from the group consisting of:
i. a polynucleotide comprising the sequence set forth in SEQ ID NO:9; and
ii. a polynucleotide having at least 95% sequence identity to SEQ ID NO: 9;

wherein the Rec8 polypeptide is selected from the group consisting of:
i. a polypeptide that is encoded by a nucleic acid molecule comprising a nucleotide sequence that is at least 95% identical to SEQ ID NO:9;

c) eliminating in the maize plant the OSD1-1A activity of an endogenous OSD1-1A polynucleotide or polypeptide, wherein OSD1-1A polynucleotide is selected from the group consisting of:
i. a polynucleotide that encodes the polypeptide of SEQ ID NO:4;
ii. a polynucleotide comprising the sequence set forth in SEQ ID NO:1; and
iii. a polynucleotide having at least 95% sequence identity to SEQ ID NO: 1;
wherein the OSD1-1A polypeptide is selected from the group consisting of:
i. a polypeptide that is encoded by a nucleic acid molecule comprising a nucleotide sequence that is at least 95% identical to SEQ ID NO:1;

and
d) eliminating in the maize plant the OSD1-3A activity of an endogenous OSD1-3A polynucleotide or polypeptide, wherein OSD1-3A polynucleotide is selected from the group consisting of:
i. a polynucleotide that encodes the polypeptide of SEQ ID NO:8;
ii. a polynucleotide comprising the sequence set forth in SEQ ID NO:5; and
iii. a polynucleotide having at least 95% sequence identity to SEQ ID NO:5;
wherein the OSD1-3A polypeptide is selected from the group consisting of:
i. a polypeptide that is encoded by a nucleic acid molecule comprising a nucleotide sequence that is at least 95% identical to SEQ ID NO: 5;

wherein the Spo11 activity of the endogenous Spo11 polynucleotide or polypeptide, wherein the Rec8 activity of the endogenous Rec8 polynucleotide or polypeptide, wherein the OSD1-1A activity of the endogenous OSD1-1A polynucleotide or polypeptide, wherein the OSD1-3A activity of the endogenous OSD1-3A polynucleotide or polypeptide, is eliminated by introducing a nucleotide modification into the polynucleotide sequence or nucleic acid molecule in part a), b), c), and d) respectively.

9. The method of claim 8 , wherein the maize plant is a hybrid.

10. The method of claim 8 , wherein the maize plant is a female parent.

11. The method of claim 8 , wherein the nucleotide modification is a deletion, addition, or substitution of one or more nucleotides.

12. The method of claim 8 , wherein the amino acid modification is a deletion, addition, o

Assignees

• Pioneer Hi Bred Int
• Du Pont

Inventors

• Albertsen Marc C
• Fox Tim Wayne
• Simon Marissa
• Williams Mark E

Classifications

• C07K14/415

  from plants · CPC title

• C12N15/8287 Primary

  for fertility modification, e.g. apomixis · CPC title

• Y02A40/146

  Genetically Modified [GMO] plants, e.g. transgenic plants · CPC title

• A01H6/4684 Primary

  Zea mays [maize] · CPC title